Cervix News and Research

RSS

Decrease in the use of radiotherapy procedures for the treatment of cancer in hospitals

The Department of Radiology and Physical Medicine of the Universidad de Granada, in Andalusian hospitals radiotherapy is not used as much as should be expected for the treatment of cancer, in favour of other procedures such as chemotherapy or surgery.

10 Oct 2007

Trop-2 new target for anti-tumour therapy in cancer

Italian scientists announced (Monday September 24) that they have found a new and promising target for anti-tumour therapy in cancer.

25 Sep 2007

Process of care failures in invasive cervical cancer: Systematic review and meta-analysis

The decline in cervical cancer is a success story of cancer research. Although there are reasons to be optimistic about even further decreases in cervical cancer incidence, there still remain some women who are not screened.

24 Sep 2007

Ancient mechanism for coping with stresses also gives cancer a boost

An ancient mechanism for coping with environmental stresses, including heat and toxic exposures, also helps cancerous tumors survive, reveals a new report in the Sept. 21, 2007, issue of Cell, a publication of Cell Press.

21 Sep 2007

Cervical cancer screening: Too many are left unprotected

The decline in cervical cancer is a success story of cancer research.

20 Sep 2007

The benefits of the contraceptive pill far outweigh the risks

A study by researchers in Scotland confirms that for most women who take the contraceptive pill, the benefits far outweigh any potential risks.

12 Sep 2007

Steep rises in cancers linked to excessive sun exposure, alcohol, smoking and obesity

Rates of melanoma, the most dangerous form of skin cancer, have risen by over 40 per cent in the past decade, making it the fastest rising cancer in the UK. Incidence of mouth, womb, and kidney cancers has also shown rapid increases in the last 10 years.

8 Aug 2007

Improved guidelines for providing intrauterine devices

Virginia Commonwealth University researchers have found that intrauterine devices are safe and effective in a population of women previously not considered as good candidates for this method of birth control.

6 Aug 2007

Study looks at progesterone therapy

Progesterone therapy does not reduce the chances of preterm birth in women pregnant with twins, reported researchers in a network sponsored by the National Institutes of Health.

3 Aug 2007

Progesterone injections do not prevent preterm birth in twin pregnancies

Weekly progesterone injections do not prevent premature births in women pregnant with twins, a University of North Carolina at Chapel Hill study has found.

3 Aug 2007

Active management of risk in pregnancy lowers Cesarean rates

At a time when national rates of cesarean delivery have climbed above 30%, a four-year study of patients receiving an alternative method of obstetric care experienced a significantly lower rate of cesarean births, according to a study published in the current issue of the Annals of Family Medicine .

1 Aug 2007

Implantable contraceptives are extremely effective

Although the devices are barely used in developed countries and only a bit more popular elsewhere, a new review of research suggests that implantable contraceptives are extremely effective.

25 Jul 2007

Music takes stress out of colposcopy

If a cervical smear test reveals abnormal cells the woman will be offered colposcopy, a technique that involves a doctor studying the cervix with a special microscope.

18 Jul 2007

Trial examines diaphragm use in preventing HIV in women

A clinical trial involving 5,045 women in South Africa and Zimbabwe found no statistical difference in the rate of new HIV infections in the two study arms: those who received a diaphragm plus lubricant along with male condoms for their partners and those who only received male condoms.

13 Jul 2007

Bio-adhesive vaginal foam

Foamix Ltd. has announced that the Company has been selected to present at the 34th Annual Meeting of the Controlled Release Society.

10 Jul 2007

Etravirine reduces HIV viral loads when taken with Prezista

The experimental antiretroviral drug etravirine, made by Johnson & Johnson subsidiary Tibotec Pharmaceuticals, greatly reduces HIV viral loads in people with a history of drug resistance when taken in combination with Tibotec's antiretroviral Prezista, according to two studies published Saturday in the journal The Lancet.

10 Jul 2007